Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Stinky frogs are a treasure trove of antibiotic substances

By Drug Discovery Trends Editor | January 25, 2012

FrogSome
of the nastiest smelling creatures on Earth have skin that produces the
greatest known variety of anti-bacterial substances that hold promise
for becoming new weapons in the battle against antibiotic-resistant
infections, scientists are reporting. Their research on amphibians so
smelly (like rotten fish, for instance) that scientists term them
“odorous frogs” appears in ACS’ Journal of Proteome Research.

Yun
Zhang, Wen-Hui Lee and Xinwang Yang explain that scientists long have
recognized frogs’ skin as a rich potential source of new antibiotics.
Frogs live in warm, wet places where bacteria thrive and have adapted
skin that secretes chemicals, known as peptides, to protect themselves
from infections. Zhang’s group wanted to identify the specific
antimicrobial peptides (AMPs), and the most potent to give scientists
clues for developing new antibiotics.

They
identified more than 700 of these substances from nine species of
odorous frogs and concluded that the AMPs account for almost one-third
of all AMPs found in the world, the greatest known diversity of these
germ-killing chemicals. Interestingly, some of the AMPs have a dual
action, killing bacteria directly and also activating the immune system
to assist in the battle.

The
authors acknowledge funding from the National Basic Research Program of
China and The National Natural Science Foundation of China.

Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs

SOURCE


Filed Under: Drug Discovery

 

Related Articles Read More >

The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
Bayer’s Lynkuet approved by FDA for menopausal hot flashes
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE